[This review was originally posted at the Nieman Journalism Lab on June 6, 2014.] This week’s essential reads: The key […]

[This review was originally posted at the Nieman Journalism Lab on July 12, 2013.] Snowden’s defenders and detractors: U.S. National […]

[This review was originally posted at the Nieman Journalism Lab on Aug. 31, 2012.] Apple’s big patent win: A U.S. […]

[This review was originally posted at the Nieman Journalism Lab Synthroid Mg, on June 15, 2012.]

Since there was no review last week, this review is covering two weeks.

Big cuts in the Big Easy: Three weeks after news of the New Orleans Times-Picayune's cutback to three-day-a-week publication broke, the other shoe dropped this week, as Advance Publications laid off about 200 of the paper's employees, including almost half the newsroom. About 400 employees at Advance's Alabama papers were let go, too, making it one of the largest rounds of layoffs in recent American newspaper history. Poynter's Steve Myers has a great link-filled survey of the carnage, online buying Synthroid hcl, while The New York Times' Campbell Robertson portrayed the scene in New Orleans.

The people of New Orleans were, needless to say, not pleased, and they expressed their disapproval of Advance in a variety of ways. A group of major local businesses and civic organizations formed to try to stop the changes to the paper, Synthroid forum, and several major TP advertisers signed on. A "Save Our Picayune" rally drew hundreds, and the nonprofit New Orleans news org The Lens captured the deep connection between the city's residents and its paper in a photo essay, while Poynter's Julie Moos examined the story behind it, Synthroid Mg.

Advance responded to the protests by saying it wouldn't back down from its plans and publishing a thoughtful column on the roots of the paper's changes, but it was also facing criticism from outside the city as well. The American Journalism Review's Rem Rieder criticized Advance for burying the news of its layoffs while trumpeting a positive video to readers about their coming changes. Jason Berry of The Nation gathered a variety of expert opinions, including "This is a breathtaking gamble" and “This is one of the dumbest decisions by any newspaper publisher ever."

Advance is modeling the online transition of the TP and its Alabama papers after its former newspaper in Ann Arbor, Michigan, a decision that has brought quite a bit of disdain, order Synthroid no prescription. Mary Morgan, publisher of another online news org in that city, the Ann Arbor Chronicle, described what she saw as a superficial approach to its community. Synthroid Mg, At the Atlantic, John McQuaid said Advance's online strategy is more focused on gathering clicks than doing comprehensive journalism, and at the Columbia Journalism Review, New Orleanian Harry Shearer said Advance is taking a cookie-cutter approach to journalism. Fortune's Dan Mitchell agreed, saying, Japan, craiglist, ebay, overseas, paypal,  "Advance's decision isn't an investment in the digital future -- it's simply proof that Advance wants to squeeze every nickel it can out of the operation as quickly as possible." CJR's Ryan Chittum made a similar point, expressing his disappointment that the paper is gutting its newsroom and moving to a "hamster-wheel" approach online.

The Lab's Adrienne LaFrance looked to a different model — Detroit, whose two newspapers cut daily delivery down to three days a week in 2009. She looked at the differences between the two cities and also addressed the possibility that people simply won't miss the print paper.

—

The futures of print and paywalls: The discussion about the Times-Picayune also bled into a couple of bigger debates about where the news industry is (or should be) headed. The largest one focused on what role print media should have in newspapers' future, as both the New York Times and American Journalism Review ran features focusing on the potential benefits and dangers for newspapers in moving to a digital-centric approach, Synthroid Mg. The Times looked in particular at the hamster-wheel effect of chasing pageviews in a digital-first context, while AJR looked at the possible importance of targeting niches and experimenting with different models, Synthroid cost.

GigaOM's Mathew Ingram argued that doing digital journalism makes news organizations just another voice and doing it well costs lots of money, so if you're shifting primarily as a cost-cutting move (as Advance seems to be), you shouldn't expect to retain your authoritative voice. The Guardian's Roy Greenslade disagreed about the nature of authority online, but agreed that publishers are seeing the move to digital as a cost-cutting measure rather than a way to aggressively move journalism forward.

Reuters' Jack Shafer put the issue in a different way, Where can i buy Synthroid online, describing newspapers "liquidating their goodwill" — by raising prices, cutting delivery days, and shedding reporting costs — as a way of trying to extract money out of their properties before their useful life is up. Synthroid Mg, The news execs cheapening their products might protest that they're still pouring investment into their papers, Shafer said, but "if you’re winding your company down with no strategy to wind it up, you’re burning goodwill even if you don’t acknowledge it." Ingram seized on that point and urged newspaper execs to have a real plan for digital reinvention.

The other debate that flowed out of the mess in New Orleans regarded paywalls, stemming from David Simon's May Columbia Journalism Review post arguing that failures like the Times-Picayune's will continue occurring until newspapers start charging for online content. Poynter's Andrew Beaujon gave some highlights of the long discussion in the comments of that piece, and The Batavian's Howard Owens responded with a comprehensive CJR post of his own listing 10 arguments against news paywalls. CJR blogger Ryan Chittum took up Simon's cause, Synthroid coupon, issuing a response to each of Owens' points. At the Harvard Business Review, Justin Fox said it really doesn't matter what Advance and other newspapers do — the industry has been doomed for a while, and Advance is just trying to get out in front of the collapse.

—

Apple and Facebook vs, Synthroid Mg. Google: Apple held another product release announcement this week, and, Buying Synthroid online over the counter, as usual, the tech press went ga-ga over it. If you're an Apple geek, you probably already know all the details, but if you want to gorge yourself on specs, features, and screenshots, Techmeme has everything you need, buy generic Synthroid. The big new product was Apple's iOS 6, the new platform on which the iPhone, iPad, and iPod will eventually run. TechCrunch has a good rundown of its features, as well as a few quick thoughts. Synthroid Mg, As part of its announcement, Apple introduced a new laptop, gave an update on its new desktop operating system Mountain Lion, and unveiled an iOS 6 feature called Passbook that integrates all kinds of passes and tickets. Synthroid australia, uk, us, usa, (It did not, however, open up Apple TV to outside developers, as some had expected.)

One particularly interesting announcement was the deep integration of Facebook into iOS 6, including quick sharing, Siri integration, and sharing from the App Store and Game Center. Josh Constine of TechCrunch said Apple seems to be borrowing Facebook's social graph rather than trying to do social tech itself, Synthroid interactions, and The Next Web's Drew Olanoff said Apple's new side-by-side display of Facebook and Twitter functions could lead users to see Facebook as the superior network. CNET's Larry Dignan, on the other hand, saw the Facebook integration as an oversharing nightmare waiting to happen.

There were relatively few big-picture reflections on the announcements: Tech blogger John Gruber saw an anti-Google tint to the proceedings, and Business Insider laid out the ways Apple is going after Google's products and "trying to make the web irrelevant." And here at the Lab, Online Synthroid without a prescription, Josh Benton had a few takeaways for news orgs, including advice to prepare for people to expect to talk to your app and the use of Passbook for news org membership models.

—

Making curation count: A little update on the ongoing conversation surrounding online curation and aggregation of content: It flared up a couple of weeks ago after a speaker was quoted as saying that curation was "replacing creation as a form of self-expression." That set off The Awl's Choire Sicha, who said curation was an awful, arrogant word for something that's actually just collecting other people's creative work as part of a secondary market, Synthroid Mg. Editor Erin Kissane and Pocket's Mark Armstrong both defended the practice of curation (if not the term itself) and advised a collaborative approach to improving it as a technique and as a business model.

Poynter's Andrew Beaujon summarized the discussion, tying it to a satirical post by the Washington Post's Michael Cavna. On the practical level, the Lab's Justin Ellis described how one curator, Dan Shanoff, Synthroid pictures, was able to turn his hand-picked sports aggregation site Quickish into something valuable (it was bought this week by Gannett), and Digital First Media's Steve Buttry and Mandy Jenkins outlined their vision for the news curation team they're hiring.

—

Reading roundup: Bunches of smaller stories and and discussions bubbling up over the past couple of weeks. Synthroid Mg, Here's a quick summary:

— In a significant case for the TV and online video industries, the U.S. Department of Justice is investigating several cable companies for possible antitrust violations in limiting online video use by the broadband Internet customers as a way to keep people from cutting the cord on cable. The story was first reported by the Wall Street Journal, and Mike Masnick of Techdirt laid out the government's case, Buy Synthroid online cod, which he says is a good one. Fortune, GigaOM and All Things D have analyses of what this might mean for consumers. In a related development, YouTube's head talked about the possibility of selling paid subscriptions to its videos.

— The social activism-focused magazine GOOD, launched in 2006, laid off most of its staff two weeks ago. The publication's executives reportedly wanted to become "a Reddit for social good," though they denied that characterization, Synthroid Mg. The laid-off staffers are going to produce one last magazine issue together, Synthroid natural, and they're calling it Tomorrow. Poynter's Andrew Beaujon and The Atlantic's Alexander Abad-Santos have good postmortems on what went wrong at GOOD.

— The Chicago Tribune reported that its owner, the Tribune Co., is close to emerging from bankruptcy after three and a half years there, and Ad Age reported that the company would probably sell some of its major assets, including the Tribune and the Los Angeles Times. Reuters' Jack Shafer looked at the possible futures of the Tribune Co.'s papers, and it wasn't pretty. Synthroid Mg, — Warren Buffett continues to dive deeper into the newspaper industry, buying up a 3.2% stake in the Lee Enterprises newspaper chain  as well as a small daily paper in Texas. Buffett explained his strategy to Howard Kurtz of The Daily Beast, and Andrew Beaujon of Poynter pitted that strategy against Advance's web-based one.

— AOL survived a fight from some of its major investors who believe that the hyperlocal journalism model they've pursued with Patch is a fatally flawed one, as Bloomberg Businessweek's Felix Gillette outlined. AOL had some positive numbers to throw at them this week, as Patch has posted its best traffic numbers ever.

— Finally, a couple of the many thought-provoking pieces posted over the past couple of weeks: The Lab's Adrienne LaFrance examined newsrooms' attitude toward innovation through the lens of the hypothetical (or maybe not so hypothetical!) "smart refrigerator strategy." And Arizona State j-prof Tim McGuire delivered his manifesto on the state of journalism and what news organizations should and shouldn't be doing in a rapidly changing media environment.

Similar posts: Purchase Retin A. Order Cephalexin. Buy Zoloft No Prescription. Armour for sale. Where can i buy Cephalexin online. Synthroid without prescription.
Trackbacks from: Synthroid Mg. Synthroid Mg. Synthroid Mg. About Synthroid. Buy Synthroid online cod. Buy Synthroid from mexico.

[This review was originally posted at the Nieman Journalism Lab Buy Armour No Prescription, on April 13, 2012.]

Facebook scoops up Instagram: There were two billion-dollar deals in the tech world this week, and by far the bigger of the two was Facebook’s purchase of the photo-sharing app Instagram. Mathew Ingram of GigaOM has a good, quick roundup of initial reaction to the deal, but I’ll try to sort through each of the angles to the story, including what this means for Facebook, Instagram, and the tech world in general. Buy Armour online cod, The first big question was why Facebook bought Instagram, especially for so much money. The most common answer, voiced most persuasively by GigaOM’s Om Malik, was that Facebook felt threatened by Instagram’s ascendance in mobile photo sharing, one area in which Facebook has struggled. Business Insider’s Nicholas Carlson explained why Instagram does mobile photos so much better than Facebook, and Fortune’s Dan Primack suggested that Facebook panicked at all the money Instagram has raised recently, Armour maximum dosage.

The New York Times also characterized the deal as a big move by Facebook into mobile media, but there were other key aspects at work, too: Ingram said Instagram’s value lay in its network, and Wired’s Tim Carmody said what matters to Facebook is Instagram’s personal data, Buy Armour No Prescription. Rackspace’s Robert Scoble outlined some of the specifics of that data, and All Things Digital’s Lauren Goode focused on Instagram’s location data. New York’s Paul Ford said Facebook is attempting to buy Instagram’s sincerity: “Remember what the iPod was to Apple. That’s how Instagram might look to Facebook: an artfully designed product that does one thing perfectly.”

So what does this mean for Instagram. TechCrunch detailed the company’s rise, and the big concern was, Ordering Armour online, as CNN’s John Sutter put it, whether Facebook would “ruin” Instagram. Mashable’s Christina Warren urged Facebook Buy Armour No Prescription,  to keep Instagram mobile-only and keep it separate from Facebook logins, and Jolie O’Dell of VentureBeat pointed out some of the good things Facebook’s developers could do for Instagram. TechCrunch noted that Facebook’s statement that it would keep Instagram as a separate product is a big departure from Facebook’s unified approach.

That concern over Facebook ruining Instagram indicates a certain revulsion for Facebook among Instagram users, something Om Malik took note of. Forbes’ John McQuaid said the sentiments reveal our uneasiness with the utility-like role tech giants like Facebook are playing in our new social world, and The Next Web’s Courtney Boyd Myers reminded Instagram users that the fact that they loved it so much was a big part of the reason it got bought in the first place.

The next question was for the tech industry as a whole: Does Instagram’s massive purchase price signal another tech market bubble, online Armour without a prescription. The Atlantic’s Rebecca Greenfield said it’s just time to accept the existence of a social media bubble, and the Guardian’s Charles Arthur said we may not be at the peak of inflated valuations, though also at the Guardian, Dan Gillmor said we could be near the end of the bubble, Buy Armour No Prescription. But Wired’s Andy Baio crunched the numbers and said Instagram wasn’t overvalued, and if anything, the tech market is rewarding efficiency. Forbes’ Robert Hof, meanwhile, looked at whether we’ll see more social media purchases soon, Armour schedule, coming up with some reasons for a slowdown.

Finally, Poynter’s Jeff Sonderman looked at some of the ways journalists have used Instagram, and Reuters’ Jack Shafer put the deal in the context of the larger cultural shift from voice to text to images. “So, Instagram is here,” he said. “What I want to know is: Where is it going to take us?”

 

Buy Armour No Prescription, Apple, publishers, Amazon, and ebooks’ future: The ebook industry absorbed a blow this week when the U.S. Department of Justice sued Apple and five of the largest book publishers for antitrust violations involving price-fixing for ebooks, cheap Armour. (Sixteen states also filed a lawsuit of their own.) Three of the publishers — Hachette, Simon & Schuster, and HarperCollins — immediately settled with the DOJ, and Wired’s Tim Carmody explained the terms of the settlement, which will undermine the model that the publishers created with Apple, though not kill it outright. Armour duration, Apple, Penguin, and Macmillan have decided not to settle, and the latter’s CEO issued a defiant letter in response to the suit.

PaidContent’s Laura Hazard Owen wrote a fantastic explanation of what the case is about, but in short, the issue centers on what’s called agency pricing, in which the publishers set book prices, Armour blogs, rather than the retailers, and the books must be at the same price across retailers. In 2010, Apple negotiated an agency pricing model with the big book publishers for the rollout of its iPad’s iBookstore, and the DOJ objected to that as price-fixing, Buy Armour No Prescription.

The Verge’s Nilay Patel dug through more of the details from the lawsuit of the alleged price-fixing process, particularly its response to Amazon’s perceived ebook dominance. At the same time, however, Buy generic Armour, as Peter Kafka of All Things Digital noted, Apple was allegedly considering a deal to divide and share rulership over online content with Amazon. A few people said the DOJ wasn’t likely to win the suit: Law prof Richard Epstein said the agency pricing arrangement has more social and consumer benefits than a classic collusion case, and CNET concluded that Apple should be able to win its case, too. Adam Thierer of the Technology Liberation Front put the strategy in the context of copyright challenges, coming out against the suit in the process. Buy Armour No Prescription, Also this week, we found out that several of the big publishers have refused to sign their annual contracts with Amazon, as Salon’s Alexander Zaitchik reported and Laura Hazard Owen explained. The Seattle Times has been running a critical series on Amazon, Armour gel, ointment, cream, pill, spray, continuous-release, extended-release, which, as the Los Angeles Times pointed out, includes some real concern about Amazon behaving anti-competitively by selling ebooks for too little.

Publishers have argued that that’s why agency pricing is necessary: It’s the best chance to keep Amazon from undercutting publishers and laying waste to the book industry. Web thinker Tim O’Reilly said the government should be watching Amazon more closely than the five companies it just sued, but Nate Hoffelder of The Digital Reader defended Amazon, Online buying Armour, arguing that it’s helping enable an entirely new publishing model in its stead.

Christopher Mims of Technology Review said it doesn’t matter if Amazon becomes a monopoly. And GigaOM’s Mathew Ingram also said Amazon’s practices have been good for consumers and good for innovation, unlike those of the publishers: “They seem to have spent most of their time dragging their feet and throwing up roadblocks to any kind of innovation … Their defense of the agency-pricing model feels like yet another attempt to stave off the forces of disruption, Buy Armour No Prescription. Why not try to adapt instead?”

Microsoft’s big patent purchase: The other billion-dollar deal drew less attention, but could be an important one beneath the tech industry’s surface: Microsoft paid just more than $1 billion for more than 800 AOL patents, outbidding Amazon, eBay, Google, and Facebook for the intellectual property trove, comprar en línea Armour, comprar Armour baratos. The patents involve advertising, search, mobile media, and e-commerce, and includes the patents underpinning Netscape, as All Things D reported. Effects of Armour, CNET’s Jay Greene and Stephen Shankland described a few of the more interesting patents potentially involved in the deal and pointed out that Microsoft’s work may have been closer to AOL’s than any other potential buyer. Dealbook’s Michael de la Merced characterized the deal as part of a “gold rush” on patents in the tech world. Buy Armour No Prescription, On AOL’s end, The New Yorker’s Nicholas Thompson worried that the money from the deal will go to appease shareholders rather than create new products, and ZDNet’s Andrew Nusca was also skeptical of the sale’s value for AOL, wondering why the company couldn’t take advantage of the patents itself. “To me, AOL’s decision to sell this part of the portfolio shows a lack of confidence in its ability to execute in these areas,” he wrote.

Remembering Mike Wallace: One of the most legendary figures in the news industry died last weekend — Mike Wallace, longtime journalist for CBS and 60 Minutes in particular. The New York Times has a definitive obituary, Armour online cod, and CBS has some more personal remembrances. The Times also collected responses to Wallace’s death, in which he was remembered as a tough-minded reporter: The New Yorker’s Ken Auletta described him as a pioneer of investigative journalism on television. Likewise, New York’s Matt Zoller Seitz gave a thoughtful appreciation of Wallace’s “informed showmanship”: “He was our stand-in, asking the questions that we might have asked if we were there and had his skill and nerve.”

Others had more personal stories: The legendary investigative reporter Seymour Hersh, longtime Philly television columnist Gail Shister, j-prof Dan Kennedy, and The Wrap’s Sharon Waxman, Buy Armour No Prescription. As Kennedy wrote: “I really do think there was a golden age of television news, and Wallace was right in the middle of it.”

Reading roundup: Plenty of other interesting pieces to keep up with this week:

— A few more takes on last week’s purchase of the Philadelphia Inquirer and Daily News by a group of local investors: The New York Times’ David Carr mused on the return of the newspaper baron, the American Journalism Review’s John Morton examined the recent spree of newspaper purchases in a downtime for the industry, Purchase Armour online no prescription, and Penn prof Victor Pickard argued for more systemic solutions to save papers like Philly’s.

— A couple of interesting pieces from the academic view of journalism: NYU’s Jay Rosen and MIT’s Ethan Zuckerman talked about trends in journalism at an MIT forum (summarized well by Matt Stempeck), and CUNY’s C.W. Anderson talked a bit about his research on data journalism to Tyler Dukes of Reporters’ Lab.

— The debate over the value of online commenting continues: Animal’s Joel Johnson proposed that comments are worth far less than publishers think, because they don’t draw many readers and don’t make money, but GigaOM’s Mathew Ingram countered that comments are an important check on online authority and that not allowing them tells readers to “go away.”

— News analyst Alan Mutter made the age-old argument that newspapers are failing in their digital efforts in a brief, potent piece decrying newspapers’ poor digital products and weak competitive response, and urging them to pool their efforts.

— Finally, Digital First Media’s Steve Buttry wrote a gracious but no-nonsense letter to newsroom curmudgeons defending digital journalism practices, then wrote about what he learned from its fallout, then addressed the role of news organizations themselves in enabling curmudgeonhood. The posts and comments are a good glimpse into the current state of newsroom culture and change.

Similar posts: Retin A Mg. Buy Diflucan No Prescription. Synthroid For Sale. Discount Glucophage. Get Synthroid. Tramadol pics.
Trackbacks from: Buy Armour No Prescription. Buy Armour No Prescription. Buy Armour No Prescription. Low dose Armour. Order Armour from United States pharmacy. Armour gel, ointment, cream, pill, spray, continuous-release, extended-release.